Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiepileptic Efficacy and Safety”

56 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 56 results

Not applicableStudy completedNCT01283256
What this trial is testing

Evaluate the Safety and Efficacy of Zonisamide an Antiepileptic Drug as Monotherapy or Adjunctive Therapy in Treatment of Adult Patients With Partial, Generalized or Combined Seizures.

Who this might be right for
Partial, Generalized and Combined Seizures
Eisai Inc. 655
Testing effectiveness (Phase 2)Study completedNCT00524056
What this trial is testing

A Proof of Concept Study of the Effectiveness of Carisbamate in the Treatment of Essential Tremor

Who this might be right for
Essential Tremor, Movement Disorders
SK Life Science, Inc. 62
Large-scale testing (Phase 3)Study completedNCT00310375
What this trial is testing

Open-label Extension Study of the Phase 3 VRX-RET-E22-301 Double-Blind Trial

Who this might be right for
Epilepsy
GlaxoSmithKline 181
Testing effectiveness (Phase 2)Study completedNCT00512317
What this trial is testing

Open-label Extension to Protocol 1042-0600

Who this might be right for
Epilepsies, Partial
Marinus Pharmaceuticals 123
Testing effectiveness (Phase 2)Study completedNCT04244175
What this trial is testing

A Trial of the Efficacy and Safety of CVL-865 as Adjunctive Therapy in the Treatment of Focal Onset Seizures

Who this might be right for
Seizures
AbbVie 154
Large-scale testing (Phase 3)Study completedNCT01963208
What this trial is testing

Phase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label Extension

Who this might be right for
Drug Resistant Partial Onset Seizure
Marinus Pharmaceuticals 405
Large-scale testing (Phase 3)Study completedNCT00210782
What this trial is testing

A Comparison of the Effectiveness and Safety of Topiramate and Phenytoin in Patients With New Onset Epilepsy Requiring Rapid Initiation of Antiepileptic Drug Treatment

Who this might be right for
Epilepsy
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 262
Large-scale testing (Phase 3)Ended earlyNCT00563459
What this trial is testing

Carisbamate Retention Study (CaReS): Comparative Study on the Long Term Effectiveness, Safety and Tolerability of Carisbamate Compared to Two Other Frequently Prescribed Anti-epileptic Drugs (AEDs) in Patients With Epilepsy.

Who this might be right for
EpilepsySeizures
SK Life Science, Inc. 89
Not applicableLooking for participantsNCT05459597
What this trial is testing

Antiepileptic Drugs in Elderly Patients

Who this might be right for
Seizure, Epileptic
Wei Zhao 500
Large-scale testing (Phase 3)Study completedNCT00425282
What this trial is testing

The Efficacy and Safety of RWJ-333369 as add-on Therapy in the Treatment of Partial Onset Seizures.

Who this might be right for
EpilepsyEpilepsy, FocalSeizure Disorder+2 more
SK Life Science, Inc. 566
Large-scale testing (Phase 3)Ended earlyNCT04320940
What this trial is testing

Efficacy and Safety of Intravenous Phenobarbital in Neonatal Seizures

Who this might be right for
Epilepsy, Benign Neonatal
NEMA Research, Inc. 4
Large-scale testing (Phase 3)Study completedNCT00280696
What this trial is testing

Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset Seizures

Who this might be right for
Epilepsies, Partial
UCB Japan Co. Ltd. 352
Large-scale testing (Phase 3)Study completedNCT00236704
What this trial is testing

The Efficacy and Safety of Topiramate as "Add on" Treatment in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures

Who this might be right for
EpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80
Testing effectiveness (Phase 2)Study completedNCT01527006
What this trial is testing

Pharmacokinetics, Efficacy, and Safety of Perampanel Oral Suspension on Seizure Frequency in Pediatric Subjects Maintained on One to Three Stable Antiepileptic Drugs

Who this might be right for
Central Nervous System
Eisai Inc. 63
Testing effectiveness (Phase 2)Study completedNCT05159908
What this trial is testing

Investigate How Effective, Safe and Tolerable the Drug NBI-921352 is When Used With Anti-seizure Medications in Adults With Focal Onset Seizures

Who this might be right for
Focal Onset SeizureFocal Onset Epilepsy
Neurocrine Biosciences 101
Large-scale testing (Phase 3)Study completedNCT00236717
What this trial is testing

The Effectiveness and Safety of Topiramate Compared With a Standard Therapy in Patients Newly Diagnosed With Epilepsy

Who this might be right for
EpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 865
Large-scale testing (Phase 3)Study completedNCT00232596
What this trial is testing

Retigabine (Adjunctive Therapy) Efficacy and Safety Study for Partial Onset Refractory Seizures in Epilepsy

Who this might be right for
Seizures
GlaxoSmithKline 306
Large-scale testing (Phase 3)Study completedNCT00236418
What this trial is testing

The Efficacy and Safety of Topiramate in Epilepsy Patients With Primary Generalized Tonic-clonic Seizures

Who this might be right for
EpilepsySeizures
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 80
Testing effectiveness (Phase 2)Study completedNCT01147003
What this trial is testing

Efficacy and Safety of BGG492 as Adjunctive Treatment in Patients With Partial Onset Seizures

Who this might be right for
Partial Onset Seizures
Novartis 93
Large-scale testing (Phase 3)Study completedNCT00991757
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Who this might be right for
EpilepsyComplex Partial SeizuresEpilepsy, Complex Partial+1 more
SK Life Science, Inc. 991
Next Page